Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.

@article{Pasquini2010HematopoieticSC,
  title={Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.},
  author={Marcelo C Pasquini and Linda M. Griffith and Douglas L. Arnold and Harold L. Atkins and J D Bowen and Jacqueline Tien-Hsiang Chen and M. S. Freedman and George Howard Kraft and Giovanni Luigi Mancardi and Roland Martin and Paolo Antonio Muraro and Richard A. Nash and Michael Karl Racke and Jan Storek and Riccardo Saccardi},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2010},
  volume={16 8},
  pages={1076-83}
}
Clinical investigation of autologous hematopoietic stem cell transplantation (HSCT) as therapy for multiple sclerosis (MS) has been ongoing for over a decade. While several phase II studies have been finalized or are in progress, no definitive prospective randomized studies comparing HSCT versus alternative therapies for MS have been completed. In this conference report of North American and European experts who are involved in the care of MS patients, including neurologists and HSCT physicians… CONTINUE READING